Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1324-1329

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jensen, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jensen, J. S.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1324-1329.)
© 1995 American Heart Association, Inc.


Articles

Renal and Systemic Transvascular Albumin Leakage in Severe Atherosclerosis

Jan Skov Jensen

From Steno Diabetes Center, Gentofte, and The Copenhagen City Heart Study, Rigshospitalet University Hospital, Copenhagen, Denmark.

Correspondence to Jan Skov Jensen, MD, Steno Diabetes Center, Niels Steensensvej 2, DK-2820 Gentofte, Denmark.

Abstract Microalbuminuria was recently proposed as a novel atherogenic risk factor. The pathophysiological link between microalbuminuria and atherosclerosis may be mediated through an increased generalized transvascular leakage of albumin. To investigate this hypothesis, urinary albumin excretion and clearance and systemic transvascular albumin leakage (TERalb) were measured in 23 patients with severe clinical atherosclerosis and 25 healthy controls. In addition, renal clearances of three other endogenous plasma proteins (IgG, IgG4, and ß2-microglobulin) and of creatinine were measured. Measurements of urine and serum proteins were done by enzyme-linked immunosorbent assays. TERalb was measured by the fractional disappearance rate of 125I-albumin from the total intravascular compartment in 1 hour after intravenous injection. Glomerular filtration rate was estimated as creatinine clearance. Urinary albumin excretion (geometric means [95% confidence intervals], 10.5 [6.1 to 18.3] versus 5.7 [4.7 to 6.9] µg/min; P<.05), fractional urinary albumin clearance (2.8 [1.6 to 4.8] x10-6 versus 1.3 [1.0 to 1.6] x10-6; P<.05), and TERalb (6.0 [5.5 to 6.5] versus 5.1 [4.5 to 5.8] %/h; P<.05) were higher in patients than in control subjects. Glomerular charge selectivity (ratio of IgG clearance to IgG4 clearance) was lower in patients than in control subjects (1.5 [1.1 to 2.0] versus 2.3 [2.0 to 2.6]; P<.05). These alterations were independent of blood pressure, glomerular filtration rate, tubular function, and smoking status. It is concluded that atherosclerotic vascular disease is associated with renal and systemic transvascular leakiness for albumin. Theoretically, such leakiness may in addition allow for an increased lipid insudation into the large vessel wall, thereby linking microalbuminuria to atherogenesis. The lower glomerular charge selectivity is suggestive of decreased concentration of anionic components in the vessel walls.


Key Words: atherosclerosis • microalbuminuria • urinary albumin excretion • systemic transvascular albumin leakage • glomerular charge selectivity




This article has been cited by other articles:


Home page
Eur Heart JHome page
M. Bohm, M. Thoenes, H.-R. Neuberger, S. Graber, J.-C. Reil, P. Bramlage, and M. Volpe
Atrial fibrillation and heart rate independently correlate to microalbuminuria in hypertensive patients
Eur. Heart J., June 1, 2009; 30(11): 1364 - 1371.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
P. A. Sarafidis and G. L. Bakris
Microalbuminuria and chronic kidney disease as risk factors for cardiovascular disease
Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2366 - 2374.
[Full Text] [PDF]


Home page
ANGIOLOGYHome page
A. Tsakiris, M. Doumas, D. Lagatouras, G. Vyssoulis, E. Karpanou, N. Nearchou, C. Kouremenou, and P. Skoufas
Microalbuminuria Is Determined by Systolic and Pulse Pressure Over a 12-Year Period and Related to Peripheral Artery Disease in Normotensive and Hypertensive Subjects: The Three Areas Study in Greece (TAS-GR)
Angiology, May 1, 2006; 57(3): 313 - 320.
[Abstract] [PDF]


Home page
Arch Intern MedHome page
J. R. Madison, C. Spies, I. J. Schatz, K. Masaki, R. Chen, K. Yano, and J. D. Curb
Proteinuria and Risk for Stroke and Coronary Heart Disease During 27 Years of Follow-up: The Honolulu Heart Program.
Arch Intern Med, April 24, 2006; 166(8): 884 - 889.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
C. A. Geluk, F. W. Asselbergs, H. L. Hillege, S. J.L. Bakker, P. E. de Jong, F. Zijlstra, and W. H. van Gilst
Impact of statins in microalbuminuric subjects with the metabolic syndrome: a substudy of the PREVEND Intervention Trial
Eur. Heart J., July 1, 2005; 26(13): 1314 - 1320.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Kornerup, B. G. Nordestgaard, T. K. Jensen, B. Feldt-Rasmussen, J. P. Eiberg, K. S. Jensen, and J. S. Jensen
Transendothelial exchange of low-density lipoprotein is unaffected by the presence of severe atherosclerosis
Cardiovasc Res, November 1, 2004; 64(2): 337 - 345.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
K. Klausen, K. Borch-Johnsen, B. Feldt-Rasmussen, G. Jensen, P. Clausen, H. Scharling, M. Appleyard, and J. S. Jensen
Very Low Levels of Microalbuminuria Are Associated With Increased Risk of Coronary Heart Disease and Death Independently of Renal Function, Hypertension, and Diabetes
Circulation, July 6, 2004; 110(1): 32 - 35.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. S. Jensen, B. Feldt-Rasmussen, K. S. Jensen, P. Clausen, H. Scharling, and B. G. Nordestgaard
Transendothelial lipoprotein exchange and microalbuminuria
Cardiovasc Res, July 1, 2004; 63(1): 149 - 154.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. T. Lane
Microalbuminuria as a marker of cardiovascular and renal risk in type 2 diabetes mellitus: a temporal perspective
Am J Physiol Renal Physiol, March 1, 2004; 286(3): F442 - F450.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
M. F. Yuyun, K.-T. Khaw, R. Luben, A. Welch, S. Bingham, N. E. Day, and N. J. Wareham
A Prospective Study of Microalbuminuria and Incident Coronary Heart Disease and Its Prognostic Significance in a British Population: The EPIC-Norfolk Study
Am. J. Epidemiol., February 1, 2004; 159(3): 284 - 293.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al.
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
Hypertension, November 1, 2003; 42(5): 1050 - 1065.
[Full Text] [PDF]


Home page
CirculationHome page
M. J. Sarnak, A. S. Levey, A. C. Schoolwerth, J. Coresh, B. Culleton, L. L. Hamm, P. A. McCullough, B. L. Kasiske, E. Kelepouris, M. J. Klag, et al.
Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention
Circulation, October 28, 2003; 108(17): 2154 - 2169.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Kornerup, B. G. Nordestgaard, B. Feldt-Rasmussen, K. Borch-Johnsen, K. S. Jensen, and J. S. Jensen
Transvascular Low-Density Lipoprotein Transport in Patients With Diabetes Mellitus (Type 2): A Noninvasive In Vivo Isotope Technique
Arterioscler Thromb Vasc Biol, July 1, 2002; 22(7): 1168 - 1174.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
J. P Garg and G. L Bakris
Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease
Vascular Medicine, February 1, 2002; 7(1): 35 - 43.
[Abstract] [PDF]


Home page
Vasc MedHome page
R. Pedrinelli, G. Dell'Omo, G. Penno, and M. Mariani
Non-diabetic microalbuminuria, endothelial dysfunction and cardiovascular disease
Vascular Medicine, November 1, 2001; 6(4): 257 - 264.
[Abstract] [PDF]


Home page
CirculationHome page
M. Roest, J. D. Banga, W. M. T. Janssen, D. E. Grobbee, J. J. Sixma, P. E. de Jong, D. de Zeeuw, and Y. T. van der Schouw
Excessive Urinary Albumin Levels Are Associated With Future Cardiovascular Mortality in Postmenopausal Women
Circulation, June 26, 2001; 103(25): 3057 - 3061.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. S. Jensen, B. Feldt-Rasmussen, S. Strandgaard, M. Schroll, and K. Borch-Johnsen
Arterial Hypertension, Microalbuminuria, and Risk of Ischemic Heart Disease
Hypertension, April 1, 2000; 35(4): 898 - 903.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Tsimikas, B. P. Shortal, J. L. Witztum, and W. Palinski
In Vivo Uptake of Radiolabeled MDA2, an Oxidation-Specific Monoclonal Antibody, Provides an Accurate Measure of Atherosclerotic Lesions Rich in Oxidized LDL and Is Highly Sensitive to Their Regression
Arterioscler Thromb Vasc Biol, March 1, 2000; 20(3): 689 - 697.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
K. Borch-Johnsen, B. Feldt-Rasmussen, S. Strandgaard, M. Schroll, and J. S. Jensen
Urinary Albumin Excretion : An Independent Predictor of Ischemic Heart Disease
Arterioscler Thromb Vasc Biol, August 1, 1999; 19(8): 1992 - 1997.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
R. Pedrinelli, G. Penno, G. Dell'Omo, S. Bandinelli, D. Giorgi, V. Di Bello, M. Nannipieri, R. Navalesi, and M. Mariani
Transvascular and Urinary Leakage of Albumin in Atherosclerotic and Hypertensive Men
Hypertension, August 1, 1998; 32(2): 318 - 323.
[Abstract] [Full Text] [PDF]